A treatment to prevent RSV in children up to two years old has been approved by the US Food and Drug Administration
The US Food and Drug Administration has approved the first treatment for preventing severe respiratory syncytial virus infections in children and infants.
RSV is a common virus that circulates in the autumn and winter. Most children with RSV usually experience mild, cold-like symptoms, but some – especially those exposed to the virus for the first time – can develop life-threatening respiratory diseases such as pneumonia and bronchiolitis. The treatment, called Beyfortus, is a single dose given by injection before or during a baby’s first RSV season. Children up to 2 years old who remain
during their second RSV season, such as those with chronic lung or heart disease, are also eligible for the shot.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA approves new drug to protect babies from RSVThe FDA approved a new drug to protect babies from RSV, the leading cause of hospitalization for U.S. infants.
Leer más »
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold seasonLast year, a surge in RSV cases flooded U.S. hospitals with wheezing children. There are no vaccines for babies yet, though Pfizer and other companies are working on them.
Leer más »
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold seasonLast year, a surge in RSV cases flooded U.S. hospitals with wheezing children. There are no vaccines for babies yet, though Pfizer and other companies are working on them.
Leer más »
FDA approves drug to prevent RSV for young childrenThe Food and Drug Administration announced Monday it has approved a new drug to prevent RSV in babies and toddlers for the first time.
Leer más »
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold seasonU.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year.
Leer más »